Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Juvenile idiopathic arthritis"

Fecal Metabolomics Implicate Tryptophan Pathway in Pediatric Spondyloarthritis

Lara C. Pullen, PhD  |  December 12, 2016

Using metabolomic profiling of fecal samples of children with enthesitis-related arthritis (ERA), researchers found that children with ERA may have lower levels of tryptophan metabolites. This finding may be attributable to differences in the gut microbiota that contribute to their pro-inflammatory phenotype…

New Criteria Released for Macrophage Activation Syndrome in Juvenile Idiopathic Arthritis

Susan Bernstein  |  August 10, 2016

Although most systemic juvenile idiopathic arthritis patients don’t develop macrophage activation syndrome (MAS), the approximately 10% who do have this serious complication can experience widespread, massive inflammation, debilitating symptoms and even death. To improve understanding of MAS among physicians and advance efforts to develop effective therapies to treat it, a panel of 28 international pediatric…

Pediatric to Adult Care Transition Challenging for Patients with JIA

Pediatric to Adult Care Transition Challenging for Patients with JIA

Lynn R. Spiegel, MD, FRCPC  |  May 15, 2015

Dr. Sheffield is an adult rheumatologist who received the following referral request from a family doctor: “Please see this 22-year-old male with a history of juvenile arthritis for ongoing care. I have only seen him once, and have no previous medical records.” Dr. Sheffield meets with Paul, who reports that he has had arthritis since…

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Boris Hugle, MD, MSc, Laura Mueller & Thierry Levade, MD, PhD  |  June 1, 2014

A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA

Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA

Exploring Kawasaki Disease

Mary Beth Son, MD  |  April 2, 2014

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

PR-COIN Initiative Takes Aim at Juvenile Idiopathic Arthritis

Mary Beth Nierengarten  |  June 1, 2013

The Pediatric Rheumatology Care and Outcomes Improvement Network uses clinical evidence and a network of collaborators to improve outcomes for children with JIA

Aggressive Treatment of Inflammation Prevents Vision Loss in Patients with JIA-related Uveitis

Lara C. Pullen, PhD  |  January 24, 2013

A new study confirms that the use of immunosuppressive drugs is associated with a reduced risk of vision loss in patients with juvenile idiopathic arthritis-related uveitis.

The ACR Honors Contributions to Rheumatology

Richard Quinn  |  December 1, 2012

The American College of Rheumatology (ACR) recognizes a group of distinguished individuals for their contributions to rheumatology research, education, and patient care

Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology

Prakash Pispati  |  October 1, 2012

Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences